摘要
大量证据表明慢性脑灌注不足是阿尔茨海默病的相关发病机理。中年肥胖与老年认知丧失及AD发生的风险相关。脑血流量与内皮细胞释放的NO合成作用增加相关,肥胖可以减少脑血流量,也可以增强氧化应激反应。升高的血浆不对称性二甲基精氨酸水平通过抑制NO合成酶活性减少NO产生,从而导致AD病人的脑灌注不足及认知和神经退行性病变。脂联素通过eNOS依赖机制对大脑产生保护作用。肥胖诱导的内皮功能紊乱和脑灌注不足可以增强β淀粉样蛋白的产生,转而损害内皮功能。这种恶性循环,促进了病变而导致AD的形成。通过增强NO对脑血流量的调节作用打破这种循环,预期促进预防AD 发病源。本文对预防或治疗措施的研究进展进行了总结,包括体育运动、营养充足的饮食摄入、药物治疗如乙酰胆碱抑制剂和抗氧化剂、及肥胖外科手术,他们对保护和延缓认知丧失及神经退化的过程很有效。
关键词: 阿尔茨海默病,β淀粉样,脑血流量,内皮功能,一氧化氮,肥胖
Current Alzheimer Research
Title:Obesity-Induced Cerebral Hypoperfusion Derived from Endothelial Dysfunction: One of the Risk Factors for Alzheimer's Disease
Volume: 11 Issue: 8
Author(s): Noboru Toda, Kazuhide Ayajiki and Tomio Okamura
Affiliation:
关键词: 阿尔茨海默病,β淀粉样,脑血流量,内皮功能,一氧化氮,肥胖
摘要: Increasing evidence supports the idea that chronic hypoperfusion in the brain is responsible for the pathogenesis underling Alzheimer’s disease (AD). Obesity at midlife is associated with the risk of cognitive loss and AD at later life. Obesity decreases cerebral blood flow that is associated with decreased synthesis and actions of nitric oxide (NO) derived from the endothelium and also increases the production of oxidative stress. Increased plasma levels of asymmetric dimethylarginine decreases the production of NO by inhibiting NO synthase activity, leading to cerebral hypoperfusion and cognitive and neurodegenerative changes in AD. Adiponectin has a cerebroprotective action through an eNOSdependent mechanism. Obesity-induced endothelial dysfunction and cerebral hypoperfusion enhance the production of β-amyloid that in turn impairs endothelial function; this vicious cycle promotes the pathogenic changes leading to AD. Interrupting this cycle by enhancement of NO-mediated cerebral blood flow is expected to promote prophylaxis against AD pathogenesis. This review summarizes recent advances in prophylactic or therapeutic measures, including physical exercise, nutritionally adequate dietary intake, pharmacological treatments such as acetylcholinesterase inhibitors and antioxidants, and bariatric surgery that are efficient in protecting and retarding the progress of cognitive failure and neurodegeneration.
Export Options
About this article
Cite this article as:
Noboru Toda, Kazuhide Ayajiki and Okamura Tomio, Obesity-Induced Cerebral Hypoperfusion Derived from Endothelial Dysfunction: One of the Risk Factors for Alzheimer's Disease, Current Alzheimer Research 2014; 11 (8) . https://dx.doi.org/10.2174/156720501108140910120456
DOI https://dx.doi.org/10.2174/156720501108140910120456 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Update in the Management of Diastolic Heart Failure
Current Vascular Pharmacology Novel Therapies for Schizophrenia: Understanding the Glutamatergic Synapse and Potential Targets for Altering N-methyl-D-aspartate Neurotransmission
Recent Patents on CNS Drug Discovery (Discontinued) Nonbacterial Thrombotic Endocarditis (Marantic Endocarditis) in Cancer Patients
Cardiovascular & Hematological Disorders-Drug Targets Drug-Drug Interactions Associated with Antiplatelet Therapy
Cardiovascular & Hematological Agents in Medicinal Chemistry Contemporary Management of Hypertension - How to Optimize Therapy
Cardiovascular & Hematological Disorders-Drug Targets Arterial Ischemic Stroke in Neonates and Children: Review and Current Issues
Current Pediatric Reviews Mitochondria-Mediated Oxidative Stress: Old Target for New Drugs
Current Medicinal Chemistry Potential Anticancer Agents. I. Synthesis of Isoxazole Moiety Containing Quinazoline Derivatives and Preliminarily in vitro Anticancer Activity
Anti-Cancer Agents in Medicinal Chemistry Editorial (Thematic Issue: Is The Female Heart Exposed To Cardiovascular Disease?)
Current Medicinal Chemistry Editorial: Statins or Fibrates for the Primary Prevention of Stroke in the Elderly. Faith Makes Some Things Achievable, But Not A
Current Vascular Pharmacology Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?
Current Vascular Pharmacology Rapid Analysis and Separation of Stilbenes
Current Analytical Chemistry Obstructive Sleep Apnea and Cardiovascular Disease - A New Target for Treatment
Current Pharmaceutical Design Impact of Matrix Metalloproteinases on Atherosclerosis
Current Drug Targets Assessment of Possible Drug Interactions in Patients with Psoriasis and Associated Comorbid Medical Conditions: An Observational Study
Reviews on Recent Clinical Trials Assessing Coronary Blood Flow Physiology in the Cardiac Catheterisation Laboratory
Current Cardiology Reviews Progress and Prospects of Stem Cells in Treatment of Drug Resistant Tuberculosis
Current Respiratory Medicine Reviews Patent Selections
Recent Patents on Cardiovascular Drug Discovery The Potential of Statins for Individualized Colorectal Cancer Chemoprevention
Current Drug Targets Smoking and Cardiovascular System: Cellular Features of the Damage
Current Pharmaceutical Design